Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

924
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
924
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

20
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

3.9K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.9K
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

5.4K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
5.4K
Documentation in Long-Term and Home Healthcare Setting01:29

Documentation in Long-Term and Home Healthcare Setting

1.5K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
1.5K
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

611
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
611

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Healthcare Resource Utilization and Cost After Temperature-Controlled Radiofrequency Treatment of Nasal Airway Obstruction: A Real-World Longitudinal Claims Analysis.

International forum of allergy & rhinology·2025
Same author

Rethinking heart failure: patient classification and treatment.

The American journal of managed care·2022
Same author

Multiple Sclerosis: Systemic Challenges to Cost-Effective Care.

American health & drug benefits·2022
Same author

Idiopathic pulmonary fibrosis: exploring the clinical and economic implications of the evolving treatment landscape.

The American journal of managed care·2021
Same author

Systemic sclerosis with associated interstitial lung disease: management considerations and future directions.

The American journal of managed care·2021
Same author

The spectrum of progressive fibrosis interstitial lung disease: clinical and managed care considerations.

The American journal of managed care·2021

Related Experiment Video

Updated: May 3, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.4K

Managed care aspects of managing multiple sclerosis.

Gary M Owens1

  • 1gowens99@comcast.net.

The American Journal of Managed Care
|February 6, 2014
PubMed
Summary

Multiple sclerosis (MS) management requires balancing patient access to treatments with rising costs. Payers need evidence-based guidelines for effective, population-based disease-modifying drug strategies.

Area of Science:

  • Neurology
  • Health Economics
  • Pharmacoeconomics

Background:

  • Multiple sclerosis (MS) is a chronic, central nervous system disease impacting young adults, disproportionately affecting women.
  • MS necessitates lifelong treatment, significantly affecting patient quality of life and imposing substantial economic burdens on individuals and healthcare systems.
  • The escalating costs and market complexity of MS therapies challenge payers and employers in managing disease effectively.

Purpose of the Study:

  • To address the need for population-based solutions and treatment algorithms for managing multiple sclerosis (MS).
  • To guide health plans and payers in balancing treatment access with cost-effectiveness in the evolving MS therapeutic landscape.
  • To inform clinical and formulary decision-making amidst a lack of head-to-head comparative data for disease-modifying drugs.

More Related Videos

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.7K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.9K

Related Experiment Videos

Last Updated: May 3, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.4K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.7K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.9K

Main Methods:

  • Review of existing evidence to develop management strategies for MS.
  • Analysis of the economic impact and market dynamics of MS therapies.
  • Identification of needs for comparative studies on disease-modifying drugs.

Main Results:

  • Current strategies for health plans are based on the best available evidence due to limited clinical guidance.
  • Insufficient head-to-head data on disease-modifying drugs hinders definitive comparative analysis.
  • The evolving therapeutic landscape necessitates continuous adaptation of management strategies.

Conclusions:

  • Effective management of multiple sclerosis (MS) requires payers to balance treatment access with cost containment.
  • Development of population-based guidelines and treatment algorithms is crucial for informed decision-making.
  • Ongoing research and comparative studies are essential to optimize MS therapy management as new agents emerge.